Contact us for your consultation (404) 554-0777
At the 22nd Annual Product Liability Seminar Continuing Legal Education (CLE) of the State Bar of Georgia, attorneys Matt Harman and Eric Fredrickson prepared a session on medical device preemption. Eric Fredrickson presented the information to the assembled attorneys on February 26, 2014. The key takeaway for plaintiff’s attorneys in medical device cases that call… Continue reading
Study Says Risk of Heart Attack Increases 2-3x for Men Taking Testosterone Therapy, Also Risk of Stroke, Pulmonary Embolism and Blood Clots A study published by the Public Library of Science One (PLoS One) found an association between testosterone therapy (TT) and cardiovascular disease. The risk for heart attack in men under the age of… Continue reading
Follow up to February 2014 Harman Law Post: FDA Requires Label Change Citing Increased Blood Clot Risk with Testosterone Products On June 19, 2014 the FDA announced they are requiring manufacturers of testosterone therapy products (“TT”) to add blood clot warnings to the drug labeling. The testosterone products include: Axiron AndroDerm AndroGel (the biggest seller… Continue reading
Today the FDA issued and posted a Class 1 recall, the most serious, for the Puritan Bennett 840 Series Ventilator by Covidien saying a software glitch may cause the device to stop working, preventing air from reaching patients who may not be able to breathe on their own and causing serious injury or death. “Class… Continue reading
Accidents, injuries and happen. Justice should be yours. When accidents happen through no fault of your own, or you’re taken advantage of financially, the attorneys at Harman Law know how to level the playing field to fight for the justice you deserve. Why choose Harman Law? Watch Matt Harman and his team plan their strategy… Continue reading
by Eric Fredrickson, Esq., Harman Law LLC GlaxoSmithKline has announced major changes to its drug marketing efforts. First, the sixth largest pharmaceutical manufacturer will stop paying doctors to promote its drugs. Second, GlaxoSmithKline will no longer tie the compensation of its sales representatives to the number of prescriptions written. These are very welcome developments for… Continue reading
The FDA announced this week that the drug Onfi (clobazam), manufactured by Lundbeck, Inc. “can cause rare but serious skin reactions that can result in permanent harm and death.” All cases known by the FDA have resulted in hospitalization, including one patient who became blind and another who died. Several lawsuits have been filed on… Continue reading
by Eric Fredrickson, Esq., Harman Law LLC A bipartisan group of lawmakers in the U.S. House of Representatives pushed for H.R. 3309, ironically titled the “Innovation Act,” that drastically curtails the ability of patent holders to enforce their intellectual property rights. The bill passed the House today, December 5 with a 325-91 vote. The bill… Continue reading
A Trial Lawyer’s Playbook. When one football team goes up against another, both the teams may be very evenly matched on paper. What tips the balance in favor of one team over another? A good coach will consider factors beyond the team’s wins and losses. Where is the game being played, is your team the… Continue reading
The FDA has republished a Class 1 recall, the most serious, for the Hospira Inc. GemStar Infusion System. The GemStar pump by Hospira is designed to deliver fluids via IV, to lower back or spinal areas, and in other parts of the body. It is small, lightweight and can be portable when using battery power.… Continue reading
Based on 23 reviews
JarrettMatt has been a warrior during our long and difficult battle for justice.
JasonAfter my grandparents were victims of fraud, Matt fought for their rights.
Denise B.When my child died because of gross negligence, the Harman Law Firm got justice for his memory.
3975 Roswell Road NE
Atlanta, GA, 30342
Phone: (404) 554-0777
[email protected]
